Plozalizumab

Item number	Size	Manual	Delivery time	Price
TGM-T77118-1mg	1 mg	-	7 - 10 business days*	364.00€
TGM-T77118-5mg	5 mg	-	7 - 10 business days*	973.00€
TGM-T77118-10mg	10 mg	-	7 - 10 business days*	1,540.00€
TGM-T77118-25mg	25 mg	-	7 - 10 business days*	2,286.00€
TGM-T77118-50mg	50 mg	-	7 - 10 business days*	3,092.00€
TGM-T77118-100mg	100 mg	-	7 - 10 business days*	4,172.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody... more

Close menu

Product information "Plozalizumab"

Description: Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma. Target: CCR. References: Jahchan NS, et al. Tuning the Tumor Myeloid Microenvironment to Fight Cancer. Front Immunol. 2019 Jul 25,10:1611.

Keywords:	MLN-1202
Supplier:	TargetMol
Supplier-Nr:	T77118

Properties

Conjugate:

Database Information

KEGG ID :	K04177 \| Matching products
UniProt ID :	P41597 \| Matching products
Gene ID :	GeneID 729230 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Plozalizumab"

Write a review